Japan Tobacco buys CLEW: a PMTA application instead of Nordic Spirit in the US
Short answer: Japan Tobacco (JT) already owns a pouch brand in Nordic Spirit, but chose to buy its way into the US. What JT is paying for is, first of all, a PMTA application already filed with the FDA, plus the CLEW brand and its formulations. That route is shorter than starting from scratch with an application of its own. According to JT’s press release, as reported by Tobacco Journal International, Tobacco Reporter and 2Firsts, JT acquired CLEW’s US assets from Nevcore Innovations on 10 November 2026. The price was not disclosed, and CLEW joins JTI LIGGETT, JT’s US business.

What the deal covers
| Item | What has been reported | Source |
|---|---|---|
| Buyer | Japan Tobacco Inc.; CLEW moves into JTI LIGGETT | JT via TJI, Tobacco Reporter and 2Firsts |
| Seller | Nevcore Innovations Inc. | JT via TJI and 2Firsts |
| Assets | US only: trademarks, intellectual property, formulations and a PMTA application | JT via TJI and VapeBrief |
| Closed | 10 November 2026, announced 12 November | TJI, 2Firsts |
| Price | Not disclosed; funded from existing cash | TJI, 2Firsts, VapeBrief |
| Impact on JT | “No material impact” on 2026 group results | JT via TJI and Tobacco Reporter |
| Current sales | Selected outlets in 13 US states; states, store count and volumes not disclosed | JT via TJI and 2Firsts |
What CLEW is
CLEW is a nicotine pouch brand that Nevcore has sold in the US, in flavours including Wintergreen, Spearmint, Citrus, Blueberry, Cool Mint and Original. According to 2Firsts, Nevcore announced in June 2024 that the FDA had accepted the brand’s PMTA application, covering strengths from 3 to 20 mg.
JT is buying the US assets only. Whether CLEW is sold outside the US, and what happens there if so, is not stated in JT’s announcement.
Regulatory status: filed, not authorized
CLEW has no FDA marketing order. According to 2Firsts, it is not among the FDA-authorized nicotine pouches as of 12 November 2026. The authorized group includes ZYN, on! and, since October 2026, VELO. See VELO’s FDA authorization and the PMTA process.
According to 2Firsts, Louisiana’s product directory (5 November 2026) lists 19 CLEW SKUs as approved for sale in the state, while 11 dropped out at renewal. 2Firsts notes that an “Under FDA review” label in such directories is certified by the manufacturer and is not a federal authorization.
What JT is buying, first of all, is an application already sitting with the FDA.
Why distribution is the interesting part
JT bought Vector Group for about $2.4 billion in 2024, gaining Liggett and a US cigarette network. JTI LIGGETT says it reaches more than 160,000 stores and holds over 8% of the US cigarette market. According to 2Firsts, staff at JTI LIGGETT’s booth at the NACS show in October said the company had not launched nicotine pouches in the US.
160,000 stores is capacity, not a plan. JT has not said CLEW will go through the whole network, or when.
The same week: Russia
The deal lands in the same week that the Russian state placed all seven JTI entities in Russia under temporary administration. Russia accounts for about 10% of JT Group revenue and about 25% of adjusted operating profit, according to JT’s forecast as reported by Tobacco Reporter. JT describes CLEW as small relative to the group, and it does not replace that. But it shows where JT chooses to grow.
What is still unclear
- The price and CLEW’s current revenue.
- PMTA status beyond the fact that it was filed, including whether the FDA has asked for more information.
- The distribution plan through JTI LIGGETT.
- CLEW outside the US, which is not part of the deal.
- Nordic Spirit, JTI’s European pouch brand, is not part of the deal.
Our assessment
- JT is buying time, not market share. The expensive part of the US market is the PMTA process. A filed application and existing formulations shorten the road compared with starting over with Nordic Spirit.
- The pattern holds. PMI bought Swedish Match, Altria bought on!, and Imperial bought the TJP Labs range, Black Buffalo and Helwit. Now JT is buying. The majors rarely build US pouch brands themselves; they buy them. See who owns the pouch brands.
- Distribution decides. A smaller brand with a PMTA filing plus a 160,000-store cigarette network is a different thing from CLEW in 13 states. The effect will only show once JT says how the brand reaches shelves.
What it means for you
- Smaller brands with a filed PMTA: the application is an asset the majors pay for. Document status, formulations and distribution.
- US distributors: expect JTI LIGGETT to have a pouch brand to sell in. Timing is not set.
- Investors: value the deal as an option on the US pouch market, not as a profit driver for 2026–27. JT itself says the impact is immaterial. See also the largest manufacturers.
Frequently asked questions
Who owns CLEW now? In the US, Japan Tobacco through JTI LIGGETT. The deal covers the US assets only.
Is CLEW FDA-authorized? No. A PMTA application has been filed, but no marketing order has been issued.
How much did JT pay? The price has not been disclosed.
Will CLEW or Nordic Spirit reach more US stores? JT has not announced a plan.
Primary sources
- JT Group acquires CLEW, 12 November 2026 — Tobacco Journal International
- Japan Tobacco Acquires U.S. Pouch Brand CLEW, 12 November 2026 — Tobacco Reporter
- Japan Tobacco buys CLEW, 12 November 2026 — 2Firsts
- Japan Tobacco completes CLEW nicotine pouch acquisition in 13 US states, 13 November 2026 — VapeBrief
- CLEW (brand website) — Nevcore
- All JTI Russian Entities Under Temporary Administration, 9 November 2026 — Tobacco Reporter
Want to know what the deal means for your position in the US or Europe?
Book an initial call